Arya Mariam Roy
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (13)
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2023
The human epidermal growth factor receptors (HERs) are expressed abundantly in the human body. The tumorigenic potential of HER2/neu is linked to its overexpression, amplification or somatic mutation. The HER2 gene amplification leading to protein overexpression has been reported in 25–30% of breast cancers and 10–30% of gastric/gastroesophageal cancers. While HER2 is a well-documented predictive, prognostic, and therapeutic marker in breast and gastric/gastroesophageal cancers, its relevance has also been demonstrated in multiple other malignancies. In this article, we will conduct an extensive review of current data pertaining to HER2 amplification, overexpression, or mutation in cancers other than breast and gastric cancers.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (8)
Ruth M. O’Regan
University of Rochester
Ariela Marshall
Faculty, Associate Professor
University of Minnesota
Zeynep Irem Ozay
University of Utah Health Huntsman Cancer Institute
Joseph Elijah
Assistant Clinical Professor
Northeastern University
Lubna Chaudhary
Assistant Professor
Medical College of Wisconsin
Shipra Gandhi
Emory University
Kazuaki Takabe
Alfiero Foundation Chair and Professor
Roswell Park Comprehensive Cancer Center
Sindhu Janarthanam Malapati
University of Arkansas for Medical Sciences
Make your next move.
Prepare your application
Review drafts before you send them.